Collegium Pharma (COLL) Tops Q3 EPS by 29c

Collegium Pharma (NASDAQ: COLL) reported Q3 EPS of ($0.45), $0.29 better than the analyst estimate of ($0.74).

For earnings history and earnings-related data on Collegium Pharma (COLL) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance
• Bernstein SocGen Group Reiterates Outperform Rating on Hermes International (RMS:FP) (HESAY) after cautious commentary